DCF — MAPLE GROVE HOSPITAL
Enterprise Value: $303.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$303.8M
Enterprise Value
$83.2M
PV of Cash Flows
$220.6M
PV of Terminal Value
$355.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $257.0M | $36.1M | 14.0% | $17.8M | $16.2M |
| Year 2 | $264.7M | $39.8M | 15.0% | $20.3M | $16.8M |
| Year 3 | $272.6M | $43.7M | 16.0% | $23.0M | $17.3M |
| Year 4 | $280.8M | $46.5M | 17.0% | $24.7M | $16.9M |
| Year 5 | $289.3M | $48.6M | 17.0% | $26.0M | $16.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $303.8M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$249.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.13542701554081196
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5